Causes of hospitalization and predictors of HIV-associated mortality at the main referral hospital in Sierra Leone: a prospective study.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
21 Oct 2019
Historique:
received: 18 01 2019
accepted: 12 09 2019
entrez: 23 10 2019
pubmed: 23 10 2019
medline: 4 1 2020
Statut: epublish

Résumé

HIV infection is a growing public health problem in Sierra Leone and the wider West Africa region. The countrywide HIV prevalence was estimated at 1.7% (67,000 people), with less than 30% receiving life-saving ART in 2016. Thus, HIV-infected patients tend to present to health facilities late, with high mortality risk. We conducted a prospective study of HIV inpatients aged ≥15 years at Connaught Hospital in Freetown-the main referral hospital in Sierra Leone-from July through September 2017, to assess associated factors and predictors of HIV-related mortality. One hundred seventy-three HIV inpatients were included, accounting for 14.2% (173/1221) of all hospital admissions during the study period. The majority were female (59.5%, 70/173), median age was 34 years, with 51.4% (89/173) of them diagnosed with HIV infection for the first time during the current hospitalization. The most common admitting diagnoses were anemia (48%, 84/173), tuberculosis (24.3%, 42/173), pneumonia (17.3%, 30/173) and diarrheal illness (15.0%, 26/173). CD4 count was obtained in 64.7% (112/173) of patients, with median value of 87 cells/μL (IQR 25-266), and was further staged as severe immunosuppression: CD4 < 100 cells/μL (50%, 56/112); AIDS: CD4 < 200 cells/μL (69.6%, 78/112); and late-stage HIV disease: CD4 < 350 cells/μL (83%, 93/112). Fifty-two patients (30.1%, 52/173) died during hospitalization, 23% (12/52) of them within the first week. The leading causes of death were anemia (23.1%, 12/52), pneumonia (19.2%, 10/52), diarrheal illness (15.4%, 8/52) and tuberculosis (13.6%, 7/52). Neurological symptoms, i.e., loss of consciousness (p = 0.04) and focal limb weakness (p = 0.04); alcohol use (p = 0.01); jaundice (p = 0.02); cerebral toxoplasmosis (p = 0.01); and tuberculosis (p = 0.04) were significantly associated with mortality; however, only jaundice (AOR 0.11, 95% CI [0.02-0.65]; p = 0.01) emerged as an independent predictor of mortality. HIV-infected patients account for a substantial proportion of admissions at Connaught Hospital, with a high morbidity and in-hospital mortality burden. These findings necessitate the implementation of specific measures to enhance early HIV diagnosis and expand treatment access to all HIV-infected patients in Sierra Leone.

Sections du résumé

BACKGROUND BACKGROUND
HIV infection is a growing public health problem in Sierra Leone and the wider West Africa region. The countrywide HIV prevalence was estimated at 1.7% (67,000 people), with less than 30% receiving life-saving ART in 2016. Thus, HIV-infected patients tend to present to health facilities late, with high mortality risk.
METHODS METHODS
We conducted a prospective study of HIV inpatients aged ≥15 years at Connaught Hospital in Freetown-the main referral hospital in Sierra Leone-from July through September 2017, to assess associated factors and predictors of HIV-related mortality.
RESULTS RESULTS
One hundred seventy-three HIV inpatients were included, accounting for 14.2% (173/1221) of all hospital admissions during the study period. The majority were female (59.5%, 70/173), median age was 34 years, with 51.4% (89/173) of them diagnosed with HIV infection for the first time during the current hospitalization. The most common admitting diagnoses were anemia (48%, 84/173), tuberculosis (24.3%, 42/173), pneumonia (17.3%, 30/173) and diarrheal illness (15.0%, 26/173). CD4 count was obtained in 64.7% (112/173) of patients, with median value of 87 cells/μL (IQR 25-266), and was further staged as severe immunosuppression: CD4 < 100 cells/μL (50%, 56/112); AIDS: CD4 < 200 cells/μL (69.6%, 78/112); and late-stage HIV disease: CD4 < 350 cells/μL (83%, 93/112). Fifty-two patients (30.1%, 52/173) died during hospitalization, 23% (12/52) of them within the first week. The leading causes of death were anemia (23.1%, 12/52), pneumonia (19.2%, 10/52), diarrheal illness (15.4%, 8/52) and tuberculosis (13.6%, 7/52). Neurological symptoms, i.e., loss of consciousness (p = 0.04) and focal limb weakness (p = 0.04); alcohol use (p = 0.01); jaundice (p = 0.02); cerebral toxoplasmosis (p = 0.01); and tuberculosis (p = 0.04) were significantly associated with mortality; however, only jaundice (AOR 0.11, 95% CI [0.02-0.65]; p = 0.01) emerged as an independent predictor of mortality.
CONCLUSION CONCLUSIONS
HIV-infected patients account for a substantial proportion of admissions at Connaught Hospital, with a high morbidity and in-hospital mortality burden. These findings necessitate the implementation of specific measures to enhance early HIV diagnosis and expand treatment access to all HIV-infected patients in Sierra Leone.

Identifiants

pubmed: 31638941
doi: 10.1186/s12889-019-7614-3
pii: 10.1186/s12889-019-7614-3
pmc: PMC6805411
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1320

Subventions

Organisme : University Hospitals Cleveland Medical Center/Roe Green Travel Medicine Award 2019
ID : N/A

Références

Clin Infect Dis. 2004 Jul 1;39(1):129-32
pubmed: 15206064
Lancet. 2002 Dec 14;360(9349):1921-6
pubmed: 12493258
J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):219-25
pubmed: 16186741
Lancet Infect Dis. 2014 Apr;14(4):281-90
pubmed: 24602844
AIDS. 2009 Sep 10;23(14):1881-9
pubmed: 19550291
Medicine (Baltimore). 2016 Apr;95(14):e3205
pubmed: 27057848
Afr Health Sci. 2008 Mar;8(1):8-12
pubmed: 19357726
N Engl J Med. 1991 Jun 6;324(23):1644-50
pubmed: 2030721
Chest. 1991 Jan;99(1):123-7
pubmed: 1984941
J Clin Oncol. 2019 Feb 1;37(4):296-304
pubmed: 30562130
PLoS One. 2016 May 11;11(5):e0154000
pubmed: 27166955
Clin Infect Dis. 2004 May 15;38(10):1454-63
pubmed: 15156485
AIDS Rev. 2018;20(3):174-175
pubmed: 30264829
J Antimicrob Chemother. 2019 Jul 1;74(7):2024-2029
pubmed: 30989237
AIDS. 2007 Jun 19;21(10):1301-8
pubmed: 17545706
Pan Afr Med J. 2017 May 18;27:48
pubmed: 28819470
AIDS. 1999 May 28;13(8):943-50
pubmed: 10371175
BMC Infect Dis. 2018 Jan 30;18(1):59
pubmed: 29378523
Open Forum Infect Dis. 2017 Jul 23;4(3):ofx156
pubmed: 28959700
Hepatology. 1996 Apr;23(4):728-33
pubmed: 8666325
Am J Trop Med Hyg. 2019 Jun;100(6):1521-1524
pubmed: 30938283
AIDS. 1992 Jun;6(6):571-4
pubmed: 1388879
AIDS Res Treat. 2012;2012:940580
pubmed: 23019521
J Int AIDS Soc. 2014 Apr 07;17:18797
pubmed: 24713375
Med Care. 2010 Dec;48(12):1071-9
pubmed: 21063228
Crit Care Med. 2016 Mar;44(3):e113-21
pubmed: 26901559
Pan Afr Med J. 2016 Sep 29;25:40
pubmed: 28154729
AIDS. 2008 Oct 1;22(15):1897-908
pubmed: 18784453
Clin Infect Dis. 2018 Mar 4;66(suppl_2):S126-S131
pubmed: 29514239
AIDS Rev. 2018 Apr-Jun;20(2):104-113
pubmed: 29938704
Open Forum Infect Dis. 2018 Aug 23;5(9):ofy208
pubmed: 30191158

Auteurs

Sulaiman Lakoh (S)

College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.

Darlinda F Jiba (DF)

Department of Medicine, University of Sierra Leone Teaching Hospitals Complex, Freetown, Sierra Leone.

Joseph E Kanu (JE)

College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.

Eva Poveda (E)

Group of Virology and Pathogenesis, Galicia Sur Health Research Institute (IIS Galicia Sur)-Complexo Hospitalario Universitario de Vigo, SERGAS-UVigo, Vigo, Spain.

Angel Salgado-Barreira (A)

Methodology and Statistics Unit, Galicia Sur Health Research Institute (IIS Galicia Sur)-Complexo Hospitalario Universitario de Vigo, SERGAS-UVigo, Vigo, Spain.

Foday Sahr (F)

College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.

Momodu Sesay (M)

National HIV/AIDS Secretariat, Freetown, Sierra Leone.

Gibrilla F Deen (GF)

College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.

Tom Sesay (T)

National AIDS Control Programme, Ministry of Health and Sanitation, Freetown, Sierra Leone.

Wadzani Gashau (W)

Department of Medicine, University of Sierra Leone Teaching Hospitals Complex, Freetown, Sierra Leone.

Robert A Salata (RA)

Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Division of Infectious Diseases and HIV Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.

George A Yendewa (GA)

Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA. gay7@case.edu.
Division of Infectious Diseases and HIV Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, USA. gay7@case.edu.
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. gay7@case.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH